Welcome Guest | Register / Login

COVID-19 Pipeline of Small and Mid-Cap Bio/Pharma Companies - Coronavirus Disease 2019 Sector Forecast

Table of Contents
1 COVID-19 Pipeline of Small and Mid-Cap Companies
1.1 COVID-19 Pipeline of Small and Mid-Cap Companies
1. 2 Analysis of COVID-19 Pipeline by Phase and Type
1.3 Analysis of COVID-19 Pipeline by Market Cap
2 Vaccine Development by Small and Mid-Cap Companies
2.1 COVID-19 Vaccine Pipeline by Phase and Molecule Subtype
2.2 Highest Development Phase COVID-19 Vaccine Pipeline
3 Therapeutic Development by Small and Mid-Cap Companies
3.1 COVID-19 Therapeutic Pipeline by Phase and Molecule Type
3.2 COVID-19 Biologic Therapeutic Pipeline by Phase and Molecule Subtype
3.3 Highest Development Phase COVID-19 Therapeutic Pipeline
4 COVID-19 Deals
4.1 COVID-19-related Partnership Agreements with Small and Mid-Cap Companies
4.2 COVID-19-related Licensing Agreements with Small and Mid-Cap Companies
Key Findings
Appendix
6.1 Glossary
6.2 Methodology
6.3 Related Reports
6.4 About the Authors
6.5 About GlobalData
6.6 Contact Us
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Site License: Report will be emailed in PDF and  allows only employees within the same geographical location within the organization to access it. This License type allows the report to be Printed.
Global Site License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :GlobalData
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy